NEW YORK (
, the computer and printer maker, said fiscal fourth-quarter earnings fell from a year earlier but still topped Wall Street's expectations.
said adjusted earnings per share fell 12% from last year to $1.17 per share. Adjusted net revenue for the quarter ended in October dropped 3% to $32.3 billion.
Analysts were expecting profit of $1.13 a share on sales of $32 billion.
Chief Financial Officer Catherine Lesjak said HP was "remaining cautious" about fiscal 2012, and HP forecast non-GAAP earnings of 83 cents a share for its fiscal first quarter ending in January. Wall Street's current consensus view is for a profit of $1.11 a share. For the full year, the
component sees non-GAAP earnings of at least $4 per share vs. the average analysts' estimate of $4.54 a share.
In premarket trading Tuesday, HP shares fell 1.8% to $26.37.
is raising an additional $200 million in capital through the sale of zero coupon convertible notes.
Technology Crossover Ventures will be buying the notes, and has the right to nominate one person Netflix's board.
The stock fell 3.7% to $71.75 in premarket trading Tuesday.
said fiscal fourth-quarter profit fell 3%.
The maker of Spam said net income fell to $117.3 million, or 43 cents a share, from $121.1 million, or 45 cents, last year.
Analysts were expecting a profit of 42 cents a share.
Sales rose 2% percent to $2.1 billion.
Hormel provided an outlook for 2012 above analysts' expectations.
blew past Wall Street's expectations in its fiscal fourth quarter.
reported adjusted earnings of $79 million, or 16 cents a share, for the three months ended Oct. 29. Revenue was $550 million, up 9% on a sequential basis but virtually flat from last year. .
Analysts were calling for a profit of 10 cents a share in the latest quarter on revenue of $527.4 million.
, the health care technology provider, is expected by analysts Tuesday to report earnings of 82 cents a share on revenue of $4.1 billion.
, an emergency medical response technology group, to private-equity firm Bain Capital for $487 million.
, the soup maker, is expected by analysts Tuesday to report earnings of 79 cents a share on revenue of $2.2 billion.
, the women's retailer, is expected by analysts to post third-quarter earnings of 20 cents a share on revenue of $548.5 million. Analysts surveyed by Thomson Reuters expect same-store sales for the quarter to rise mor e than 5%.
agreed on Monday to buy
for $11 billion in cash and debt, vaulting Gilead into the lead to develop the next generation of all-oral hepatitis C therapies.
The acquisition price of $137 a share was an 89% premium to Pharmasset's closing price Friday of $72.67.
Pharmasset shares rose 84.6% Monday to close at $134.14.
-- Written by Joseph Woelfel
>To contact the writer of this article, click here:
>To submit a news tip, send an email to:
Copyright 2011 TheStreet.com Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed. AP contributed to this report.